Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall survival.
ICD CSD
Study Director
Sanofi
United States: Food and Drug Administration
EFC4690
NCT00094081
October 2002
September 2006
Name | Location |
---|---|
Stanford University Medical Center | Stanford, California 94305-5408 |
Medical University of South Carolina | Charleston, South Carolina 29425-0721 |
University of Rochester Medical Center | Rochester, New York 14642 |
Eastern Virginia Medical School | Norfolk, Virginia 23507 |
Foundation for Cancer Research and Education | Phoenix, Arizona 85013 |
University of Chicago Medical Center | Chicago, Illinois 60637 |
Johns Hopkins Hospital | Baltimore, Maryland 21287 |
H-Lee Moffitt Cancer Center and Research | Tampa, Florida 33612 |
Harper Hospital | Detroit, Michigan 48201 |
VA New Jersey Health Care Medical Center | East Orange, New Jersey 07018 |